<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-X27J3MLA</identifier><date>1999</date><creator>Kokelj, F...</creator><creator>Plozzer, C...</creator><creator>Trevisan, G...</creator><relation>documents/doc/X/URN_NBN_SI_doc-X27J3MLA_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-X27J3MLA_001.txt</relation><format format_type="issue">3</format><format format_type="volume">8</format><format format_type="type">article</format><format format_type="extent">str. 101-104</format><identifier identifier_type="COBISSID_HOST">10701273</identifier><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-X27J3MLA</identifier><language>eng</language><publisher publisher_location="Ljubljana">Slovene Welding Society</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="slv">Adverse effects</subject><subject language_type_id="slv">Cyclosporine</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">Etretinate</subject><subject language_type_id="slv">Psoriasis</subject><subject language_type_id="slv">Retinoids</subject><subject language_type_id="slv">Vitamin d</subject><title>Adverse events due to psoriasis treatment</title></Record>